Patient treatment preference in advanced breast cancer: A randomized cross-over study of doxorubicin and mitozantrone
Authors:
- R.J. SimesRSR.J. Simes
- A.S. CoatesACA.S. Coates
- D. RaghavanDRD. Raghavan
- R. DevineRDR. Devine
- M.H.N. TattersallMTM.H.N. Tattersall
- 13 May 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (5) , 557-561
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A comparison of mitoxantrone and doxorubicin in breast cancer.Journal of Clinical Oncology, 1986
- Determining Optimal Therapy — Randomized Trials in Individual PatientsNew England Journal of Medicine, 1986
- A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancerInvestigational New Drugs, 1985
- Treatment selection for cancer patients: Application of statistical decision theory to the treatment of advanced ovarian cancerJournal of Chronic Diseases, 1985
- Crossover and Self-Controlled Designs in Clinical ResearchNew England Journal of Medicine, 1984
- Mitoxantrone versus doxorubicin in advanced breast cancer: A randomized cross-over trialCancer Treatment Reviews, 1983
- On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Chemotherapy of breast cancer a general overviewCancer, 1983
- Reporting results of cancer treatmentCancer, 1981
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979